Autolus Therapeutics to Participate in William Blair’s Biotech Focus Conference 2022, New York, July 12 – 13, 2022
Autolus Therapeutics (Nasdaq: AUTL) announced its participation in William Blair’s Biotech Focus Conference 2022 in New York City on July 12. CEO Dr. Christian Itin will join a panel discussion titled ‘Operationalizing Cell Therapies’ from 8:55 to 10:15 am ET. The company aims to advance next-generation programmed T cell therapies for cancer treatment. With proprietary technologies, Autolus develops targeted T cell therapies designed to combat various cancers, focusing on hematological malignancies and solid tumors.
- None.
- None.
LONDON, July 06, 2022 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announces that management will be attending William Blair’s Biotech Focus Conference 2022 at The St. Regis New York in New York City. Autolus’ Chief Executive Officer, Dr. Christian Itin, will participate in a panel discussion on ‘Operationalizing Cell Therapies’ on Tuesday, July 12 at 8.55 – 10.15 am ET (1:55 pm – 3.15 pm BST) and the Company will also be attending one-on-one investor meetings at the event.
About Autolus Therapeutics plc
Autolus is a clinical-stage biopharmaceutical company developing next-generation, programmed T cell therapies for the treatment of cancer. Using a broad suite of proprietary and modular T cell programming technologies, the Company is engineering precisely targeted, controlled and highly active T cell therapies that are designed to better recognize cancer cells, break down their defense mechanisms and eliminate these cells. Autolus has a pipeline of product candidates in development for the treatment of hematological malignancies and solid tumors. For more information, please visit www.autolus.com.
Contact:
Olivia Manser
+44 (0) 7780 471568
o.manser@autolus.com
Julia Wilson
+44 (0) 7818 430877
j.wilson@autolus.com
Susan A. Noonan
S.A. Noonan Communications
+1-917-513-5303
susan@sanoonan.com
FAQ
When is Autolus Therapeutics presenting at the 2022 Biotech Focus Conference?
Who will represent Autolus at the Biotech Focus Conference?
What is the topic of the panel discussion featuring Autolus at the conference?
What kind of therapies is Autolus developing?
What is the focus of Autolus' product pipeline?
